![](/img/cover-not-exists.png)
Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation
Ferris, Robert L., Lenz, Heinz-Josef, Maria Trotta, Anna, García-Foncillas, Jesús, Schulten, Jeltje, Audhuy, François, Merlano, Marco, Milano, GerardLanguage:
english
Journal:
Cancer Treatment Reviews
DOI:
10.1016/j.ctrv.2017.11.008
Date:
December, 2017
File:
PDF, 1.59 MB
english, 2017